These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6408547)

  • 21. A phase I-II study of continuous 5-day infusion mitomycin-C.
    Yap HY; Valdivieso M; Blumenschein G; Hortobagyi G; Bedikian A
    Am J Clin Oncol; 1983 Feb; 6(1):109-12. PubMed ID: 6404154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial.
    Joensuu H; Holli K; Heikkinen M; Suonio E; Aro AR; Hietanen P; Huovinen R
    J Clin Oncol; 1998 Dec; 16(12):3720-30. PubMed ID: 9850014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin and mitomycin C in advanced chemotherapy-refractory breast cancer.
    Crivellari D; Galligioni E; Frustaci S; Foladore S; Lo Re G; Morassut S; Monfardini S
    Tumori; 1990 Jun; 76(3):234-7. PubMed ID: 2114683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer.
    Rausa L; Russo A; Gebbia V; Gebbia N; D'Alessandro N; Palmeri S
    J Cancer Res Clin Oncol; 1991; 117(3):266-8. PubMed ID: 1709643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-line and salvage therapy of metastatic breast cancer with mitomycin/vinblastine.
    Sedlacek SM
    Oncology; 1993 Apr; 50 Suppl 1():16-21. PubMed ID: 8483557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitomycin-C in breast cancer.
    Hortobagyi GN
    Semin Oncol; 1985 Dec; 12(4 Suppl 6):65-70. PubMed ID: 3936183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitomycin-C and vinblastine in advanced breast cancer.
    Navarro M; Bellmunt J; Balañá C; Colomer R; Jolis L; del Campo JM
    Oncology; 1989; 46(3):137-42. PubMed ID: 2497417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitomycin C: phase I study of a constant infusion ambulatory treatment schedule.
    Lokich J; Perri J; Fine N; Bothe A; Nelson T; Greene R; Zipoli T
    Am J Clin Oncol; 1982 Aug; 5(4):443-7. PubMed ID: 7113965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute dyspnea following intravenous administration of vinblastine/mitomycin C].
    Lagler U; Gattiker HH
    Schweiz Med Wochenschr; 1989 Mar; 119(9):290-2. PubMed ID: 2496465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer.
    Dieras V; Marty M; Tubiana N; Corette L; Morvan F; Serin D; Mignot L; Chazard M; Garet F; Onetto N
    Semin Oncol; 1995 Aug; 22(4 Suppl 8):33-9. PubMed ID: 7638640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patients.
    Ardizzoni A; Pronzato P; Conte PF; Rosso R
    Chemioterapia; 1984 Apr; 3(2):83-5. PubMed ID: 6442624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancer.
    Falkson G; Gelman RS; Tormey DC; Taylor SG; Falkson HC
    Cancer Treat Rep; 1985; 69(7-8):755-60. PubMed ID: 4016786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer.
    Hsu C; Yeh KH; Hong RL; Yang CH; Lin MT; Chen YC; Cheng AL
    J Formos Med Assoc; 1997 Mar; 96(3):185-8. PubMed ID: 9080756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of mitomycin regimens in advanced breast cancer therapy.
    Legha SS
    Clin Ther; 1985; 7(3):286-307. PubMed ID: 3888391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study.
    Andersson M; Daugaard S; von der Maase H; Mouridsen HT
    Cancer Treat Rep; 1986 Oct; 70(10):1181-6. PubMed ID: 3530444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mitomycin C and high-dosage medroxyprogesterone acetate in the therapy of metastasizing breast cancer. Results of a phase II study of the Workshop for Internal Oncology of the German Cancer Association].
    Bartsch HH; Blossey HC; Nagel GA
    Onkologie; 1982 Oct; 5(5):249-57. PubMed ID: 6218456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of 7-N-(p-hydroxyphenyl)-mitomycin C (KW2083) in patients with advanced non-small cell carcinoma of the lung and metastatic pulmonary tumors.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H; Hoshi A
    Jpn J Clin Oncol; 1985 Mar; 15(1):61-5. PubMed ID: 3981815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Third-line chemotherapy with mitomycin, vinblastine, and carmustine (BCNU) in refractory breast carcinoma: a pilot study.
    Veronesi A; Tirelli U; Galligioni E; Trovò MG; Crivellari D; Donatella Magri M; Roncadin M; Tumolo S; Grigoletto E
    Cancer Treat Rep; 1982 Mar; 66(3):559-61. PubMed ID: 7060044
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
    Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
    Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin, mitolactol (dibromodulcitol), and mitomycin C treatment for patients with metastatic breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone (CMFVP).
    DiStefano A; Yap HY; Blumenschein GR
    Cancer Treat Rep; 1981; 65(1-2):33-8. PubMed ID: 7013977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.